The Cardiovascular Safety of Incretin-Based TherapiesThe Cardiovascular Safety of Incretin-Based Therapies
Do controlled trials find that 'gliptins' increase risk for adverse cardiac events? Cardiovascular Diabetology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Health | Heart | Incretin Therapy